Surface topologized ovalbumin scaffolds containing YIGSR peptides for modulating Schwann cell behavior

Int J Biol Macromol. 2023 Dec 31;253(Pt 4):127015. doi: 10.1016/j.ijbiomac.2023.127015. Epub 2023 Sep 25.

Abstract

Peripheral nerve injuries (PNI) currently have limited therapeutic efficacy, and functional scaffolds have been shown to be effective for treating PNI. Ovalbumin (OVA) is widely used as a natural biomaterial for repairing damaged tissues due to its excellent biocompatibility and the presence of various bioactive components. However, there are few reports on the repair of PNI by ovalbumin. In this study, a novel bionic functionalized topological scaffold based on ovalbumin and grafted with tyrosine-isoleucine-glycine-serine-arginine (YIGSR) peptide was constructed by micro-molding method and surface-biomodification technology. The scaffolds were subjected to a series of evaluations in terms of morphology, mechanics, hydrophilicity, and biocompatibility, and the related molecular mechanisms were further penetrated. The results showed that the scaffolds prepared in this study had aligned ridge/groove structure, good mechanical properties and biocompatibility, and could be used as carriers to slowly release YIGSR, which effectively promoted the proliferation, migration and elongation of Schwann Cells (SCs), and significantly up-regulated the gene expression related to proliferation, apoptosis, migration and axon regeneration. Therefore, the bionic functional topological scaffold has significant application potential for promoting peripheral nerve regeneration and provides a new therapeutic option for repairing PNI.

Keywords: Growth regulation; OVA scaffold; Schwann cells; Topology; YIGSR peptide.

MeSH terms

  • Axons*
  • Humans
  • Nerve Regeneration / physiology
  • Ovalbumin / metabolism
  • Peptides / chemistry
  • Peripheral Nerve Injuries* / therapy
  • Schwann Cells
  • Tissue Scaffolds / chemistry

Substances

  • tyrosyl-isoleucyl-glycyl-seryl-arginine
  • Ovalbumin
  • Peptides